🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jefferies Group’s OMDA Holdings & Trades

First Buy
Q4 2025
Duration Held
1 Quarters
Largest Add
Q4 2025
+1.07 M Shares
Current Position
1.07 M Shares
$16.95 M Value

Jefferies Group's OMDA Position Overview

Jefferies Group (via Jefferies Financial Group Inc.) currently holds 1.07 M shares of Omada Health, Inc. (OMDA) worth $16.95 M, representing 0.09% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Jefferies Group has initiated a new position in OMDA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Jefferies Group's Omada Health (OMDA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Omada Health (OMDA) Trades by Jefferies Group

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +1.07 M New Buy 1.07 M $15.78

Jefferies Group's Omada Health Investment FAQs

Jefferies Group first purchased Omada Health, Inc. (OMDA) in Q4 2025, acquiring 1,073,991 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jefferies Group has held Omada Health, Inc. (OMDA) for 1 quarters since Q4 2025.

Jefferies Group's largest addition to Omada Health, Inc. (OMDA) was in Q4 2025, adding 1,073,991 shares worth $16.95 M.

According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 1,073,991 shares of Omada Health, Inc. (OMDA), valued at approximately $16.95 M.

As of the Q4 2025 filing, Omada Health, Inc. (OMDA) represents approximately 0.09% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.

Jefferies Group's peak holding in Omada Health, Inc. (OMDA) was 1,073,991 shares, as reported at the end of Q4 2025.